Modifying factors of PD‐L1 expression on tumor cells in advanced non‐small‐cell lung cancer
Sign Up to like & getrecommendations! Published in 2022 at "Thoracic Cancer"
DOI: 10.1111/1759-7714.14695
Abstract: Programmed death ligand‐1 (PD‐L1) expression predicts immunotherapy utility in nononcogenic addictive lung adenocarcinoma (ADC). However, its reproducibility and reliability may be compromised outside clinical trials. This study aimed to evaluate factors associated with PD‐L1 expression… read more here.
Keywords: factors expression; modifying factors; lung; expression tumor ... See more keywords